There is a new FDA-approved pill called Addyi that is supposed to help women in boosting their libido. This medication is meant for women who suffer from hypoactive sexual desire disorder which is a sudden and unexplained lack of desire for sex. This pill is to be aimed at pre-menopausal women who want to boost their desire for sex. Many people argue that the FDA is sexist in rejecting the approval of this drug many times before approving it where as Viagra was approved in significantly less time by the FDA. But I disagree with the people who say that the FDA in being sexist in not approving Addyi at first.

For starters, Viagra effects the flow of blood to the penis. It is a drug that sparks a pure physical reaction in men that aids them in getting and keeping an erection. Because this drug alters the patient physically, things are going well for Viagra and there has even been a three year follow up article on how good Viagra is for you and there is nothing but positive tests and statistics. Surely, the FDA saw how positive the drug Viagra was and that is why they wasted no time in passing their approval. I can understand why the FDA hesitated to approve the drug Addyi because it is a drug that alters a woman’s sex drive neurologically. Anytime you mess with the chemical components of the brain, you are bound to run into risks. And after some tests, Addyi did prove to be risky when women test subjects claimed to wake up feeling groggy as well as reporting very high blood pressure levels when using the drug with alcohol in their system. Before approval of the drug, Addyi had to make an agreement with the FDA that they would continue to preform safety experiments with the drug.

The FDA is not out to be sexist, they are simply trying to protect the public from new and unknown medications that could affect our health. And as women, we should stand behind that, not against it.